On the strength of phase 2 data, the FDA has awarded coveted breakthrough status to Pfizer's vaccine against Group B Streptococcus (GBS), given to expectant mothers to prevent invasive infections ...

Background: Although intrapartum antimicrobial prophylaxis has lowered the incidence of early onset group B Streptococcus (GBS) sepsis, there are concerns that the increased use of antibiotics may ...

Gestation at <37 weeks, duration of membrane rupture of ≥18 hours, or temperature of ≥100.4 ºF (≥38.0 ºC) are clinical indications for intrapartum prophylaxis if the GBS status is unknown ...